The median survival time after EPP was significantly longer in 21 patients who received additional chemotherapy...
Raleigh, NC (PRWEB) September 26, 2017
Japanese scientists have found that mesothelioma patients who undergo lung-removing extrapleural pneumonectomy (EPP) surgery are more likely to get the best outcomes if they have aggressive follow-up treatments, too. Surviving Mesothelioma has the full story. Click here to read it now.
According to doctors at the Hyogo College of Medicine, mesothelioma patients who completed more than three cycles of systemic chemotherapy when their cancer returned after EPP had the best long-term outcomes.
“The median survival time after EPP was significantly longer in 21 patients who received additional chemotherapy than in 18 patients who did not,” writes Teruhisa Takuwa, lead author on the paper.
The study, published in the International Journal of Clinical Oncology, found that the median survival among pleural mesothelioma patients who had chemotherapy after post-surgical mesothelioma recurrence was more than three years. In contrast, the non-chemotherapy group had a post-surgical survival time of just over a year.
“The bottom line here is that, for optimal odds of surviving mesothelioma, EPP must be just the beginning, not an end to treatment,” says Alex Strauss, Managing Editor for Surviving Mesothelioma.
For more on the value and importance of aggressive mesothelioma treatment after EPP surgery, see Radical Surgery Alone Unlikely to Prolong Mesothelioma Survival, now available on the Surviving Mesothelioma website.
For more than a decade, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.